Amicus Therapeutics
Amicus Therapeutics
Company
| Legal Name | Amicus Therapeutics Inc |
| Headquarters | Princeton, United States |
| Website | https://amicusrx.com |
About Amicus Therapeutics
Amicus Therapeutics develops drugs that treat rare genetic diseases known as lysosomal storage disorders. Unlike other treatments which replace defective enzymes, Amicus uses small molecule pharmacological "chaperones" which bind to a patient's own defective proteins and restore their functions. Its lead drug candidate, Amigal, is aimed at aiding patients with Fabry disease. Another candidate, Plicera, is in development to treat Gaucher disease, while a third candidate, AT2220 is targeting Pompe disease. The company is also researching treatments for neurodegenerative diseases including Alzheimer's and Parkinson's.
Synonyms
amicus therapeuticsamicus therapeutics incHiring Locations
| Country | City | Job Ads |
|---|---|---|
| United Kingdom | Marlow | 47 |
| United States | Princeton | 36 |
| Ireland | Dublin | 19 |
| United States | Philadelphia | 16 |
| Canada | Montréal | 5 |
| France | Paris | 5 |
Headquarters
Loading map...
Company Info
Legal Form: Inc
Company Type: Public
Company Size: 51 - 250
Revenue: 1 - 5 million (USD)
Job Ad Metrics
Job Ads found: 128
Job Ads per Month: 3.5
Hiring Locations: 6
Data Info
| Date of first job ad | 25.11.2019, 13:37 |
| Date of last job ad | 04.12.2025, 14:36 |
| Date merged | 11.12.2025, 09:43 |
| Date created | 25.11.2019, 13:37 |